Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome

Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome

Little is known about evolution of platelet count after treatment with direct-acting antiviral agents (DAAs). The study aimed to evaluate the changes in platelet count after treatment with DAAs among thrombocytopenic patients with HCV-related advanced fibrosis and cirrhosis. A total of 915 chronic H...

Full description

Bibliographic Details
Main Authors: Zeinab Soliman, Mohamed El Kassas, Aisha Elsharkawy, Mohamed Elbadry, Yasser Hamada, Ramy ElHusseiny, Saeed M. El-Nahaas, Rabab Fouad, Gamal Esmat, Shereen Abdel Alem
Format: Article
Language:English
Published: Taylor & Francis Group 2021-04-01
Series:Platelets
Subjects:
advanced fibrosis
chronic hepatitis c virus
direct-acting antiviral agents
outcome
platelets
thrombocytopenia
Online Access:http://dx.doi.org/10.1080/09537104.2020.1742313

Similar Items

Similar Items